
    
      Part 1: Approximately 66 subjects will be randomized in a 1:1:1 ratio to the following dose
      groups:

        -  Zimura Dose Administration 1

        -  Zimura Dose Administration 2

        -  Sham Administration 1

      Part 2: Approximately 135 subjects will be randomized in a 1:2:2 ratio to the following dose
      groups:

        -  Zimura Dose Administration 3

        -  Zimura Dose Administration 4

        -  Sham Administration 2

      Subjects will receive monthly intravitreal injections of Zimura or Sham for 18 months.
    
  